Proton beam dosimetry in the presence of magnetic fields using Farmer-type ionization chambers of different radii.

MR-guided proton therapy dosimetry ionization chamber magnetic fields

Journal

Medical physics
ISSN: 2473-4209
Titre abrégé: Med Phys
Pays: United States
ID NLM: 0425746

Informations de publication

Date de publication:
Jul 2023
Historique:
revised: 14 02 2023
received: 27 10 2022
accepted: 06 03 2023
medline: 11 7 2023
pubmed: 21 3 2023
entrez: 20 3 2023
Statut: ppublish

Résumé

Magnetic resonance-guided proton therapy is promising, as it combines high-contrast imaging of soft tissue with highly conformal dose delivery. However, proton dosimetry in magnetic fields using ionization chambers is challenging since the dose distribution as well as the detector response are perturbed. This work investigates the effect of the magnetic field on the ionization chamber response, and on the polarity and ion recombination correction factors, which are essential for the implementation of a proton beam dosimetry protocol in the presence of magnetic fields. Three Farmer-type cylindrical ionization chambers, the 30013 with 3 mm inner radius (PTW, Freiburg, Germany) and two custom built chambers "R1" and "R6" with 1 and 6 mm inner radii respectively were placed at the center of an experimental electromagnet (Schwarzbeck Mess - Elektronik, Germany) 2 cm depth of an in-house developed 3D printed water phantom. The detector response was measured for a 3 × 10 cm At both energies, the ionization chamber PTW 30013 showed a non-linear response as a function of the magnetic field strength, with a decrease of the ionization chamber response of up to 0.27% ± 0.06% (1 SD) at 0.2 Tesla, followed by a smaller effect at higher magnetic field strength. For the chamber R1, the response decreased slightly with the magnetic field strength up to 0.45% ± 0.12% at 1 Tesla, and for the chamber R6, the response decreased up to 0.54% ± 0.13% at 0.1 Tesla, followed by a plateau up to 0.3 Tesla, and a weaker effect at higher magnetic field strength. The dependence of the polarity and recombination correction factor on the magnetic field was ⩽0.1% for the chamber PTW 30013. The magnetic field has a small but significant effect on the chamber response in the low magnetic field region for the chamber PTW 30013 and for R6, and in the high magnetic field region for the chamber R1. Corrections may be necessary for ionization chamber measurements, depending on both the chamber volume and the magnetic flux density. No significant effect of the magnetic field on the polarity and recombination correction factor was detected in this work for the ionization chamber PTW 30013.

Sections du résumé

BACKGROUND BACKGROUND
Magnetic resonance-guided proton therapy is promising, as it combines high-contrast imaging of soft tissue with highly conformal dose delivery. However, proton dosimetry in magnetic fields using ionization chambers is challenging since the dose distribution as well as the detector response are perturbed.
PURPOSE OBJECTIVE
This work investigates the effect of the magnetic field on the ionization chamber response, and on the polarity and ion recombination correction factors, which are essential for the implementation of a proton beam dosimetry protocol in the presence of magnetic fields.
METHODS METHODS
Three Farmer-type cylindrical ionization chambers, the 30013 with 3 mm inner radius (PTW, Freiburg, Germany) and two custom built chambers "R1" and "R6" with 1 and 6 mm inner radii respectively were placed at the center of an experimental electromagnet (Schwarzbeck Mess - Elektronik, Germany) 2 cm depth of an in-house developed 3D printed water phantom. The detector response was measured for a 3 × 10 cm
RESULTS RESULTS
At both energies, the ionization chamber PTW 30013 showed a non-linear response as a function of the magnetic field strength, with a decrease of the ionization chamber response of up to 0.27% ± 0.06% (1 SD) at 0.2 Tesla, followed by a smaller effect at higher magnetic field strength. For the chamber R1, the response decreased slightly with the magnetic field strength up to 0.45% ± 0.12% at 1 Tesla, and for the chamber R6, the response decreased up to 0.54% ± 0.13% at 0.1 Tesla, followed by a plateau up to 0.3 Tesla, and a weaker effect at higher magnetic field strength. The dependence of the polarity and recombination correction factor on the magnetic field was ⩽0.1% for the chamber PTW 30013.
CONCLUSIONS CONCLUSIONS
The magnetic field has a small but significant effect on the chamber response in the low magnetic field region for the chamber PTW 30013 and for R6, and in the high magnetic field region for the chamber R1. Corrections may be necessary for ionization chamber measurements, depending on both the chamber volume and the magnetic flux density. No significant effect of the magnetic field on the polarity and recombination correction factor was detected in this work for the ionization chamber PTW 30013.

Identifiants

pubmed: 36940235
doi: 10.1002/mp.16368
doi:

Substances chimiques

Protons 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

4590-4599

Subventions

Organisme : DKFZ International PhD Program in Heidelberg
Organisme : Participating States and from the European Union's Horizon 2020 research and innovation programme
ID : 19NRM01 MRgRT-DOS
Organisme : German Federal Ministry of Education and Research: Image Guided Diagnostics and Therapy - New Directions in Intervention
Organisme : ARTEMIS project
ID : 13GW0436A

Informations de copyright

© 2023 The Authors. Medical Physics published by Wiley Periodicals LLC on behalf of American Association of Physicists in Medicine.

Références

Grégoire V, Guckenberger M, Haustermans K, et al. Image guidance in radiation therapy for better cure of cancer. Mol Oncol. 2020;14(7):1470-1491. doi: 10.1002/1878-0261.12751
Paganelli C, Whelan B, Peroni M, et al. MRI-guidance for motion management in external beam radiotherapy: current status and future challenges. Phys Med Biol. 2018;63(22):22TR03. doi: 10.1088/1361-6560/aaebcf
Raaymakers BW, Jürgenliemk-Schulz IM, Bol GH, et al. First patients treated with a 1.5 T MRI-Linac: clinical proof of concept of a high-precision, high-field MRI guided radiotherapy treatment. Phys Med Biol. 2017;62(23):L41-L50. doi: 10.1088/1361-6560/aa9517
Nachbar M, Mönnich D, Boeke S, et al. Partial breast irradiation with the 1.5 T MR-Linac: first patient treatment and analysis of electron return and stream effects. Radiother Oncol. 2020;145:30-35. doi: 10.1016/j.radonc.2019.11.025
Barnes H, Alexander S, Bower L, et al. Development and results of a patient-reported treatment experience questionnaire on a 1.5 T MR-Linac. Clin Transl Radiat Oncol. 2021;30:31-37. doi: 10.1016/j.ctro.2021.06.003
Wegener D, Zips D, Gani C, et al. [Primary treatment of prostate cancer using 1.5 T MR-linear accelerator]. Radiologe. 2021;61(9):839-845. doi: 10.1007/s00117-021-00882-8
Hoegen P, Spindeldreier CK, Buchele C, et al. Magnetic-resonance-guided radiotherapy: the beginning of a new era in radiation oncology? Radiologe. 2021;61(1):13-20. doi: 10.1007/s00117-020-00761-8
Raaymakers BW, Raaijmakers AJE, Lagendijk JJW. Feasibility of MRI guided proton therapy: magnetic field dose effects. Phys Med Biol. 2008;53(20):5615-5622. doi: 10.1088/0031-9155/53/20/003
Moteabbed M, Schuemann J, Paganetti H. Dosimetric feasibility of real-time MRI-guided proton therapy: dosimetric feasibility of real-time MRI-guided proton therapy. Med Phys. 2014;41(11):111713. doi: 10.1118/1.4897570
Schellhammer SM, Hoffmann AL, Gantz S, et al. Integrating a low-field open MR scanner with a static proton research beam line: proof of concept. Phys Med Biol. 2018;63(23):23LT01. doi: 10.1088/1361-6560/aaece8
Hoffmann A, Oborn B, Moteabbed M, et al. MR-guided proton therapy: a review and a preview. Radiat Oncol. 2020;15(1):129. doi: 10.1186/s13014-020-01571-x
Spindeldreier CK, Schrenk O, Bakenecker A, et al. Radiation dosimetry in magnetic fields with Farmer-type ionization chambers: determination of magnetic field correction factors for different magnetic field strengths and field orientations. Phys Med Biol. 2017;62(16):6708-6728. doi: 10.1088/1361-6560/aa7ae4
VanAsselen B, Woodings SJ, Hackett SL, et al. A formalism for reference dosimetry in photon beams in the presence of a magnetic field. Phys Med Biol. 2018;63(12):125008. doi: 10.1088/1361-6560/aac70e
Pojtinger S, Dohm OS, Kapsch RP, Thorwarth D. Ionization chamber correction factors for MR-linacs. Phys Med Biol. 2018;63(11):11NT03. doi: 10.1088/1361-6560/aac4f2
Pojtinger S, Kapsch RP, Dohm OS, Thorwarth D. A finite element method for the determination of the relative response of ionization chambers in MR-linacs: simulation and experimental validation up to 1.5 T. Phys Med Biol. 2019;64(13):135011. doi: 10.1088/1361-6560/ab2837
Pojtinger S, Nachbar M, Ghandour S, et al. Experimental determination of magnetic field correction factors for ionization chambers in parallel and perpendicular orientations. Phys Med Biol. 2020;65(24):245044. doi: 10.1088/1361-6560/abca06
Lühr A, Burigo LN, Gantz S, Schellhammer SM, Hoffmann AL. Proton beam electron return effect: Monte Carlo simulations and experimental verification. Phys Med Biol. 2019;64(3):035012. doi: 10.1088/1361-6560/aafab4
Padilla-Cabal F, Kuess P, Georg D, Palmans H, Fetty L, Fuchs H. Characterization of EBT3 radiochromic films for dosimetry of proton beams in the presence of magnetic fields. Med Phys. 2019;46(7):3278-3284. doi: 10.1002/mp.13567
Schellhammer SM, Gantz S, Lühr A, Oborn BM, Bussmann M, Hoffmann AL. Technical note: experimental verification of magnetic field-induced beam deflection and Bragg peak displacement for MR-integrated proton therapy. Med Phys. 2018;45(7):3429-3434. doi: 10.1002/mp.12961
Causer TJ, Schellhammer SM, Gantz S, et al. First application of a high-resolution silicon detector for proton beam Bragg peak detection in a 0.95 T magnetic field. Med Phys. 2020;47(1):181-189. doi: 10.1002/mp.13871
Fuchs H, Padilla-Cabal F, Zimmermann L, Palmans H, Georg D. MR-guided proton therapy: impact of magnetic fields on the detector response. Med Phys. 2021;48(5):2572-2579. doi: 10.1002/mp.14660
Vedelago J, Karger CP, Jäkel O. A review on reference dosimetry in radiation therapy with proton and light ion beams: status and impact of new developments. Radiat Meas. 2022;157:106844. doi: 10.1016/j.radmeas.2022.106844
Andreo P, Burns DT, Hohlfeld K, et al. An International Code of Practice for Dosimetry based on Standards of Absorbed Dose to Water. Published online. Absorbed dose determination in external beam radiotherapy: An international code of practice for dosimetry based on standards of absorbed dose to water. Tech. Rep. Ser. 398, (Vienna: International Atomic Energy Agency), http://www.pub.iaea.org/MTCD/publications/PDF/TRS398_scr.pdf
Combs SE, Jäkel O, Haberer T, Debus J. Particle therapy at the Heidelberg Ion Therapy Center (HIT) - integrated research-driven university-hospital-based radiation oncology service in Heidelberg, Germany. Radiother Oncol. 2010;95(1):41-44. doi: 10.1016/j.radonc.2010.02.016
Burigo LN, Oborn BM. Integrated MRI-guided proton therapy planning: accounting for the full MRI field in a perpendicular system. Med Phys. 2022;49(3):1853-1873. doi: 10.1002/mp.15398

Auteurs

Mathieu Marot (M)

German Cancer Research Center DKFZ, Medical Physics in Radiation Oncology, Heidelberg, Germany.
Faculty of Medicine, University of Heidelberg, Heidelberg, Germany.
National Center for Radiation Research in Oncology NCRO, Heidelberg Institute for Radiation Oncology HIRO, Heidelberg, Germany.

Sonja Surla (S)

German Cancer Research Center DKFZ, Medical Physics in Radiation Oncology, Heidelberg, Germany.
National Center for Radiation Research in Oncology NCRO, Heidelberg Institute for Radiation Oncology HIRO, Heidelberg, Germany.
Faculty of Physics and Astronomy, University of Heidelberg, Heidelberg, Germany.

Elisa Burke (E)

National Center for Radiation Research in Oncology NCRO, Heidelberg Institute for Radiation Oncology HIRO, Heidelberg, Germany.
Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.

Stephan Brons (S)

National Center for Radiation Research in Oncology NCRO, Heidelberg Institute for Radiation Oncology HIRO, Heidelberg, Germany.
Heidelberg Ion-Beam Therapy Center HIT, University Hospital Heidelberg, Heidelberg, Germany.

Armin Runz (A)

German Cancer Research Center DKFZ, Medical Physics in Radiation Oncology, Heidelberg, Germany.

Steffen Greilich (S)

Business Units Radiation Protection/Bioanalytics, Berthold Technologies GmbH & Co. KG, Bad Wildbad, Germany.

Christian P Karger (CP)

German Cancer Research Center DKFZ, Medical Physics in Radiation Oncology, Heidelberg, Germany.
Heidelberg Ion-Beam Therapy Center HIT, University Hospital Heidelberg, Heidelberg, Germany.

Oliver Jäkel (O)

German Cancer Research Center DKFZ, Medical Physics in Radiation Oncology, Heidelberg, Germany.
National Center for Radiation Research in Oncology NCRO, Heidelberg Institute for Radiation Oncology HIRO, Heidelberg, Germany.
Heidelberg Ion-Beam Therapy Center HIT, University Hospital Heidelberg, Heidelberg, Germany.

Lucas N Burigo (LN)

German Cancer Research Center DKFZ, Medical Physics in Radiation Oncology, Heidelberg, Germany.
National Center for Radiation Research in Oncology NCRO, Heidelberg Institute for Radiation Oncology HIRO, Heidelberg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH